01 20ARIPIPRAZOLE
02 6BREXPIPRAZOLE
03 1CEDAZURIDINE; DECITABINE
04 2CILOSTAZOL
05 1DECITABINE
06 1DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
07 1FERRIC AMMONIUM CITRATE
08 2FUTIBATINIB
09 3GREPAFLOXACIN HYDROCHLORIDE
10 1IOHEXOL
11 2TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
12 8TOLVAPTAN
13 2UREA C-13
01 1CAPSULE;ORAL
02 4FOR SOLUTION;ORAL
03 1INJECTABLE;INTRAMUSCULAR
04 1INJECTABLE;INTRAVENOUS
05 1SOLUTION;ORAL
06 2SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
07 4TABLET, ORALLY DISINTEGRATING;ORAL
08 36TABLET;ORAL
01 10.25MG
02 10.5MG
03 1100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 1100MG;35MG
05 210MG
06 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 1125MG/VIAL
08 415MG
09 115MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
10 116MG
11 11MG
12 11MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 220MG
14 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
15 120MG;10MG
16 32MG
17 430MG
18 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 13MG
20 145MG
21 24MG
22 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 150MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
24 25MG
25 1600MG/PACKET
26 160MG
27 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
28 1720MG/2.4ML (300MG/ML)
29 19.75MG/1.3ML (7.5MG/ML)
30 19.7GM/BOT
31 190MG
32 1960MG/3.2ML (300MG/ML)
33 1EQ 200MG BASE
34 1EQ 400MG BASE
35 1EQ 6.14MG BASE;15MG
36 1EQ 600MG BASE
37 1EQ 75MG/POUCH
38 1EQ 8.19MG BASE;20MG
01 23DISCN
02 27RX
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 10MG
Approval Date : 2002-11-15
Application Number : 21436
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 15MG
Approval Date : 2002-11-15
Application Number : 21436
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 20MG
Approval Date : 2002-11-15
Application Number : 21436
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 30MG
Approval Date : 2002-11-15
Application Number : 21436
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 5MG
Approval Date : 2002-11-15
Application Number : 21436
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 2MG
Approval Date : 2002-11-15
Application Number : 21436
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : SOLUTION; ORAL
Proprietary Name : ABILIFY
Dosage Strength : 1MG/ML **Federal Registe...
Approval Date : 2004-12-10
Application Number : 21713
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : INJECTABLE; INTRAMUSCULAR
Proprietary Name : ABILIFY
Dosage Strength : 9.75MG/1.3ML (7.5MG/ML)
Approval Date : 2006-09-20
Application Number : 21866
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SUSPENSION, EXTENDED RELEASE; ...
Proprietary Name : ABILIFY ASIMTUFII
Dosage Strength : 720MG/2.4ML (300MG/ML)
Approval Date : 2023-04-27
Application Number : 217006
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : SUSPENSION, EXTENDED RELEASE; ...
Proprietary Name : ABILIFY ASIMTUFII
Dosage Strength : 960MG/3.2ML (300MG/ML)
Approval Date : 2023-04-27
Application Number : 217006
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Otsuka Holdings is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find Difamilast bulk with DMF offered by Otsuka Holdings
Find Oranekishijin hydrochloride hydrate bulk with JDMF offered by Otsuka Holdings
Find Aripiprazole bulk offered by Otsuka Holdings
